Egle Therapeutics Press Release
2026-10-01

Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study

EGL-003, a selective IL-2 agonist,…
read more
ONA Press Release
2026-09-24

Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer

More than half of the…
read more
Novadip Press Release
2026-09-22

Novadip secures €10.4 million financing to complete pivotal Phase 3 trial

New funds bring total financing…
read more
ONA Press Release
2026-06-04

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

Ona Therapeutics Raises $86.6 Million…
read more
Press Release Tubulis
2026-04-07

Fund+ Portfolio Company Tubulis to be Acquired by Gilead

• Fund+ portfolio company Tubulis…
read more
Press Release TargED
2025-11-03

TargED Biopharmaceuticals to Present First Clinical and New Preclinical Data on TGD001 in Two Oral Sessions at the 2025 ASH Annual Meeting

Utrecht, November 3, 2025 -…
read more
Press Release Tubulis
2025-10-30

Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

New investors Fidelity Management &…
read more
Press Release Tubulis
2025-10-15

Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline

• USD 361 million round…
read more
Epics Therapeutics Press Release
2025-09-23

EPICS Therapeutics Announces First Cohort Dosed with EP102 in First-In-Patient Oncology Trial and Securement of Additional Financing

Gosselies, Belgium - September 22nd,…
read more
Novadip Press Release
2025-07-08

Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients

NVD003 is a bone grafting…
read more